| Identification of essential genes for cancer immunotherapy SJ Patel, NE Sanjana, RJ Kishton, A Eidizadeh, SK Vodnala, M Cam, ... Nature 548 (7669), 537-542, 2017 | 827 | 2017 |
| Preclinical mouse cancer models: a maze of opportunities and challenges CP Day, G Merlino, T Van Dyke Cell 163 (1), 39-53, 2015 | 669 | 2015 |
| Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response CN Spencer, JL McQuade, V Gopalakrishnan, JA McCulloch, M Vetizou, ... Science 374 (6575), 1632-1640, 2021 | 453 | 2021 |
| UVB-induced tumor heterogeneity diminishes immune response in melanoma Y Wolf, O Bartok, S Patkar, GB Eli, S Cohen, K Litchfield, R Levy, ... Cell 179 (1), 219-235. e21, 2019 | 335 | 2019 |
| Epigenetic therapy inhibits metastases by disrupting premetastatic niches Z Lu, J Zou, S Li, MJ Topper, Y Tao, H Zhang, X Jiao, W Xie, X Kong, ... Nature 579 (7798), 284-290, 2020 | 266 | 2020 |
| Co‐regulation of B‐Myb expression by E2F1 and EGF receptor N Hanada, HW Lo, CP Day, Y Pan, Y Nakajima, MC Hung Molecular Carcinogenesis: Published in cooperation with the University of …, 2006 | 239 | 2006 |
| TGF-β signaling in myeloid cells is required for tumor metastasis Y Pang, SK Gara, BR Achyut, Z Li, HH Yan, CP Day, JM Weiss, ... Cancer discovery 3 (8), 936-951, 2013 | 170 | 2013 |
| Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5−/− mice Y Li, R Tinoco, L Elmén, I Segota, Y Xian, Y Fujita, A Sahu, R Zarecki, ... Nature communications 10 (1), 1492, 2019 | 140 | 2019 |
| From UVs to metastases: modeling melanoma initiation and progression in the mouse MR Zaidi, CP Day, G Merlino Journal of investigative dermatology 128 (10), 2381-2391, 2008 | 139 | 2008 |
| Cancer‐specific gene therapy HW Lo, CP Day, MC Hung Advances in genetics 54, 233-255, 2005 | 123 | 2005 |
| Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy E Pérez-Guijarro, HH Yang, RE Araya, R El Meskini, HT Michael, ... Nature medicine 26 (5), 781-791, 2020 | 94 | 2020 |
| Genetically engineered mouse models of melanoma E Pérez‐Guijarro, CP Day, G Merlino, MR Zaidi Cancer 123 (S11), 2089-2103, 2017 | 94 | 2017 |
| Strength of immune selection in tumors varies with sex and age A Castro, RM Pyke, X Zhang, WK Thompson, CP Day, LB Alexandrov, ... Nature communications 11 (1), 4128, 2020 | 85 | 2020 |
| Upregulation of IKKα/IKKβ by integrin-linked kinase is required for HER2/neu-induced NF-κB antiapoptotic pathway K Makino, CP Day, SC Wang, YM Li, MC Hung Oncogene 23 (21), 3883-3887, 2004 | 84 | 2004 |
| Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis KL Marie, A Sassano, HH Yang, AM Michalowski, HT Michael, T Guo, ... Nature Communications 11 (1), 333, 2020 | 69 | 2020 |
| A direct link between MITF, innate immunity, and hair graying ML Harris, TD Fufa, JW Palmer, SS Joshi, DM Larson, A Incao, DE Gildea, ... PLoS biology 16 (5), e2003648, 2018 | 58 | 2018 |
| The suppression of colon cancer cell growth in nude mice by targetingβ-catenin/TCF pathway KY Kwong, Y Zou, CP Day, MC Hung Oncogene 21 (54), 8340-8346, 2002 | 56 | 2002 |
| Lentivirus‐mediated bifunctional cell labeling for in vivo melanoma study CP Day, J Carter, C Bonomi, D Esposito, B Crise, B Ortiz‐Conde, ... Pigment cell & melanoma research 22 (3), 283-295, 2009 | 54 | 2009 |
| Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma JS Paradis, M Acosta, R Saddawi-Konefka, A Kishore, S Lubrano, ... Clinical Cancer Research 27 (11), 3190-3200, 2021 | 53 | 2021 |
| Adenoviral E1A targets Mdm4 to stabilize tumor suppressor p53 Z Li, CP Day, JY Yang, WB Tsai, G Lozano, HM Shih, MC Hung Cancer research 64 (24), 9080-9085, 2004 | 48 | 2004 |
Nicholas P Restifo, MDCellular Immunotherapy Explorer在 marbletx.com 的电子邮件经过验证
